These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 23906113)

  • 61. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
    Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
    J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical and microbiological determinants of infection after transrectal prostate biopsy.
    Liss MA; Johnson JR; Porter SB; Johnston B; Clabots C; Gillis K; Nseyo U; Holden M; Sakamoto K; Fierer J
    Clin Infect Dis; 2015 Apr; 60(7):979-87. PubMed ID: 25516194
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complications of transrectal ultrasound-guided prostate biopsy: impact of prebiopsy enema.
    Kam SC; Choi SM; Yoon S; Choi JH; Lee SH; Hwa JS; Chung KH; Hyun JS
    Korean J Urol; 2014 Nov; 55(11):732-6. PubMed ID: 25405015
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
    Yamamoto S; Ishitoya S; Segawa T; Kamoto T; Okumura K; Ogawa O
    Int J Urol; 2008 Jul; 15(7):604-6. PubMed ID: 18462354
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
    Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
    J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Bacteriological analysis of more than 600 febrile urinary infections managed in a community health network].
    Bruyère F; Vidoni M; Péan Y; Ruimy JA; Elfassi R
    Prog Urol; 2013 Sep; 23(10):890-8. PubMed ID: 24034802
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
    Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
    BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.
    Tukenmez Tigen E; Tandogdu Z; Ergonul O; Altinkanat G; Gunaydin B; Ozgen M; Sariguzel N; Erturk Sengel B; Odabasi Z; Cek M; Tokuc R; Turkeri L; Mulazimoglu L; Korten V
    Urology; 2014 Nov; 84(5):1008-15. PubMed ID: 25239255
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.
    Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT
    Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy.
    Cam K; Kayikci A; Akman Y; Erol A
    Int J Urol; 2008 Oct; 15(11):997-1001. PubMed ID: 18721198
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy.
    Lundström KJ; Drevin L; Carlsson S; Garmo H; Loeb S; Stattin P; Bill-Axelson A
    J Urol; 2014 Oct; 192(4):1116-22. PubMed ID: 24813343
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy.
    Bulut V; Şahin AF; Balaban Y; Altok M; Divrik RT; Zorlu F
    Int Braz J Urol; 2015; 41(5):906-10. PubMed ID: 26689515
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bacterial persistence in the prostate after antibiotic treatment of chronic bacterial prostatitis in men with spinal cord injury.
    Krebs J; Bartel P; Pannek J
    Urology; 2014 Mar; 83(3):515-20. PubMed ID: 24581511
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radical prostatectomy in the presence of ongoing refractory ESBL Escherichia coli bacterial prostatitis.
    McLoughlin LC; McDermott TE; Thornhill JA
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25315803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.